Stifel Financial Corp Aquestive Therapeutics, Inc. Transaction History
Stifel Financial Corp
- $106 Billion
- Q3 2025
A detailed history of Stifel Financial Corp transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 366,428 shares of AQST stock, worth $1.98 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
366,428
Previous 374,228
2.08%
Holding current value
$1.98 Million
Previous $1.24 Million
65.43%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding AQST
# of Institutions
164Shares Held
65.9MCall Options Held
794KPut Options Held
457K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$52.9 Million100.0% of portfolio
-
Rtw Investments, LP New York, NY6.25MShares$33.7 Million0.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.66MShares$30.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$29.4 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.76MShares$20.3 Million0.05% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $288M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...